We divided CRC tissues into low FBXL8 and high FBXL8 groups and then used immunohistochemistry to analyse the expression levels of FBXL8 and p53 in CRC tissues and scored them (Figure 2A). The gene discussed is TP53; the disease is colorectal carcinoma.